Treatment of neuroendocrine or gastrointestinal tumors, using agents taken up by the monoamine transporter or benzodiazepine receptor

摘要

Use of a composition (A) containing at least one active agent (I) that is taken up by a monoamine transporter (MAT) for treatment of neuroendocrine tumors or other tumors that express MAT. Independent claims are also included for: (1) use of a composition (A1) containing at least one active agent (II) that interacts with the peripheral benzodiazepine receptor (BDAR) and/or the nucleic acid that encodes BDAR, for treatment and diagnosis of gastrointestinal tumors, especially of esophagus, stomach, pancreas, bile duct, large or small intestines, and/or lymphoma; and (2) a kit that contains at least one (A) or (A1).